1. Home
  2. NEON vs SCYX Comparison

NEON vs SCYX Comparison

Compare NEON & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$1.65

Market Cap

27.9M

Sector

Technology

ML Signal

HOLD

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$0.93

Market Cap

32.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
SCYX
Founded
1997
1999
Country
Sweden
United States
Employees
43
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
32.6M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
NEON
SCYX
Price
$1.65
$0.93
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$3.00
AVG Volume (30 Days)
96.7K
313.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
37.88
61.36
EPS
N/A
N/A
Revenue
$3,108,000.00
$257,000.00
Revenue This Year
N/A
$90.24
Revenue Next Year
$43.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$0.57
52 Week High
$29.90
$1.29

Technical Indicators

Market Signals
Indicator
NEON
SCYX
Relative Strength Index (RSI) 44.20 66.73
Support Level N/A $0.68
Resistance Level $2.04 $1.29
Average True Range (ATR) 0.09 0.06
MACD -0.00 0.01
Stochastic Oscillator 34.44 83.09

Price Performance

Historical Comparison
NEON
SCYX

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: